BEAM

#1368
Beam Therapeutics Inc. - Common Stock
32.9 3 USD
-0.12%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
32.93
32.93
년간 변동
15.35
36.44
일일 변동
-0.12%
월간 변동
+11.59%
6달 변화
+32.89%
년간 변동율
+103.90%
이전 종가
32.9 7
Open
32.9 3
저가
32.9 3
High
32.9 3
양
211
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 3.39 B
  • Employee 511
  • Founded 2017
  • CEO John Evans
  • Website www.beamtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00KXC8646
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-34.22
주가매출액비율
19.62

Beam Therapeutics Inc. - Common Stock

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

뉴스